BF-24-JN36_10uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=10uM, 6-[(3~{R})-3-oxidanylpyrrolidin-1-yl]-5-pyrimidin-5-yl-~{N}-[4-(trifluoromethyloxy)phenyl]pyridine-3-carboxamide, Allosteric ABL1 inhibitor targeting ABL1, ABL2 (Novartis, 89907349)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/89907349
Similar Terms
Downloads & Tools

Genes

11 genes differentially expressed following the BF-24-JN36_10uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
CCT7 chaperonin containing TCP1, subunit 7 (eta) 3.49594
NONO non-POU domain containing, octamer-binding 1.26126
NT5DC2 5'-nucleotidase domain containing 2 0.648746
CISD1 CDGSH iron sulfur domain 1 0.616584
EMP3 epithelial membrane protein 3 0.355232
DAD1 defender against cell death 1 0.273892
PLAC8 placenta-specific 8 0.255283
DHRS2 dehydrogenase/reductase (SDR family) member 2 0.255283
RNASEK ribonuclease, RNase K 0.242053

decreased expression

Symbol Name Standardized Value
MAGED1 melanoma antigen family D1 -0.616584
CRYAB crystallin, alpha B -0.260915